Class Central is learner-supported. When you buy through links on our site, we may earn an affiliate commission.

YouTube

The Global Preclinical Antibacterial Pipeline - Editors in Conversation

American Society for Microbiology via YouTube

Overview

Explore the global preclinical antibacterial pipeline in this 38-minute conversation with Valeria Gigante, Team Lead at the World Health Organization's AMR Division. Delve into the process of reviewing the antibacterial pipeline, recognize progress and gaps in antibiotic discovery, and identify opportunities to overcome hurdles in early-stage antibacterial research and development. Gain insights on bacterial priority pathogen lists, research targeting, innovation challenges, pipeline composition, and future prospects. Understand the importance of antibiotic discovery in combating antimicrobial resistance and the economic challenges faced by the field. Learn about the latest WHO report on preclinical and clinical antibacterial development, methodologies used, and the composition of current pipelines, including IND-enabling phases and mechanism of action considerations.

Syllabus

Introduction
Bacterial Priority Pathogen List
Research and Targeting
CDC vs WHO
WHO fungal pathogen priority list
Methodology
Innovation
Innovation vs Inhibitors
Size of antibacterial research programs
High failure rate of antibacterial compounds
Lack of interest and investment
Pipeline composition
INDEnabling Phase
Mechanism of Action
Narrow Spectrum
Preclinic Programs
Limitations
Future

Taught by

American Society for Microbiology

Reviews

Start your review of The Global Preclinical Antibacterial Pipeline - Editors in Conversation

Never Stop Learning.

Get personalized course recommendations, track subjects and courses with reminders, and more.

Someone learning on their laptop while sitting on the floor.